Grand Pharmaceutical’s new drup for treatment of brain tumors granted approval

A new drug for the treatment of brain tumors manufactured by Grand Pharmaceutical Group (HK: 0512) has been given the green light by Chinese regulators . . .

 

 

SIGN IN  OR SUBSCRIBE TO GET FULL ACCESS.

 

We build ONE TIMELINE to help you keep up with China Markets!

FREE TRIAL & ONLY $4.9 FOR A MONTH!

Start for free

One-click cancel any time!